2010 Q4 Form 10-K Financial Statement
#000119312511045739 Filed on February 25, 2011
Income Statement
| Concept | 2010 Q4 | 2010 Q3 | 2009 Q4 |
|---|---|---|---|
| Revenue | $12.79B | $11.38B | $12.20B |
| YoY Change | 4.84% | 5.65% | 9.62% |
| Cost Of Revenue | $11.61B | $10.38B | $10.99B |
| YoY Change | 5.63% | 6.08% | 11.37% |
| Gross Profit | $1.155B | $967.0M | $1.216B |
| YoY Change | -5.02% | -1.93% | -4.03% |
| Gross Profit Margin | 9.03% | 8.5% | 9.96% |
| Selling, General & Admin | |||
| YoY Change | |||
| % of Gross Profit | |||
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | -$613.0M | $213.0M | $470.0M |
| YoY Change | -230.43% | -0.93% | 101.72% |
| % of Gross Profit | -53.07% | 22.03% | 38.65% |
| Operating Expenses | $203.0M | -$88.00M | -$28.00M |
| YoY Change | -825.0% | 7.32% | -65.43% |
| Operating Profit | $1.128B | $889.0M | $1.244B |
| YoY Change | -9.32% | -16.76% | -7.72% |
| Interest Expense | -$87.00M | -$85.00M | -$86.00M |
| YoY Change | 1.16% | 14.86% | 11.69% |
| % of Operating Profit | -7.71% | -9.56% | -6.91% |
| Other Income/Expense, Net | $289.0M | $37.00M | $26.00M |
| YoY Change | 1011.54% | -31.48% | -125.49% |
| Pretax Income | $1.056B | $829.0M | $1.184B |
| YoY Change | -10.81% | -20.9% | 1.28% |
| Income Tax | -$2.093B | $272.0M | $348.0M |
| % Of Pretax Income | -198.2% | 32.81% | 29.39% |
| Net Earnings | $983.0M | $571.0M | $827.0M |
| YoY Change | 18.86% | -28.36% | 0.49% |
| Net Earnings / Revenue | 7.68% | 5.02% | 6.78% |
| Basic Earnings Per Share | $2.76 | $1.56 | $2.19 |
| Diluted Earnings Per Share | $2.73 | $1.54 | $2.17 |
| COMMON SHARES | |||
| Basic Shares Outstanding | |||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2010 Q4 | 2010 Q3 | 2009 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $2.777B | $3.423B | $2.737B |
| YoY Change | 1.46% | 26.36% | 22.79% |
| Cash & Equivalents | $2.261B | $2.656B | $2.391B |
| Short-Term Investments | $516.0M | $767.0M | $346.0M |
| Other Short-Term Assets | $2.061B | $2.148B | $1.496B |
| YoY Change | 37.77% | 35.26% | 19.11% |
| Inventory | $2.363B | $2.093B | $2.183B |
| Prepaid Expenses | |||
| Receivables | $5.692B | $6.275B | $6.061B |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $12.89B | $13.94B | $12.48B |
| YoY Change | 3.33% | 12.02% | 16.79% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $4.554B | $4.347B | $4.520B |
| YoY Change | 0.75% | -1.87% | 0.71% |
| Goodwill | $9.605B | ||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $8.061B | $7.519B | $7.855B |
| YoY Change | 2.62% | -12.44% | -6.34% |
| Total Long-Term Assets | $22.22B | $21.61B | $22.63B |
| YoY Change | -1.83% | -7.24% | -0.54% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $12.89B | $13.94B | $12.48B |
| Total Long-Term Assets | $22.22B | $21.61B | $22.63B |
| Total Assets | $35.11B | $35.55B | $35.11B |
| YoY Change | 0.01% | -0.53% | 5.0% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.627B | $2.352B | $2.030B |
| YoY Change | -19.85% | 4.77% | 0.0% |
| Accrued Expenses | $1.870B | $1.890B | $1.648B |
| YoY Change | 13.47% | 5.88% | -2.14% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | ||
| YoY Change | |||
| Total Short-Term Liabilities | $11.40B | $11.64B | $10.70B |
| YoY Change | 6.52% | 0.47% | 1.53% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $5.019B | $5.019B | $5.052B |
| YoY Change | -0.65% | 40.86% | 41.79% |
| Other Long-Term Liabilities | $15.20B | $14.98B | $15.23B |
| YoY Change | -0.2% | -14.21% | -7.54% |
| Total Long-Term Liabilities | $20.22B | $20.00B | $20.28B |
| YoY Change | -0.32% | -4.87% | 1.23% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $11.40B | $11.64B | $10.70B |
| Total Long-Term Liabilities | $20.22B | $20.00B | $20.28B |
| Total Liabilities | $31.62B | $31.63B | $30.98B |
| YoY Change | 2.05% | -2.97% | 1.33% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | |||
| YoY Change | |||
| Common Stock | |||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $3.497B | $3.918B | $3.966B |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $35.11B | $35.55B | $35.11B |
| YoY Change | 0.01% | -0.53% | 5.0% |
Cashflow Statement
| Concept | 2010 Q4 | 2010 Q3 | 2009 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $983.0M | $571.0M | $827.0M |
| YoY Change | 18.86% | -28.36% | 0.49% |
| Depreciation, Depletion And Amortization | -$613.0M | $213.0M | $470.0M |
| YoY Change | -230.43% | -0.93% | 101.72% |
| Cash From Operating Activities | -$3.387B | $513.0M | -$291.0M |
| YoY Change | 1063.92% | -63.97% | -129.19% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $394.0M | -$171.0M | -$685.0M |
| YoY Change | -157.52% | -6.04% | 61.94% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $473.0M | $108.0M | $132.0M |
| YoY Change | 258.33% | -118.09% | -728.57% |
| Cash From Investing Activities | $867.0M | -$63.00M | -$553.0M |
| YoY Change | -256.78% | -91.91% | 24.55% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 2.256B | -536.0M | 550.0M |
| YoY Change | 310.18% | -10.67% | -167.9% |
| NET CHANGE | |||
| Cash From Operating Activities | -3.387B | 513.0M | -291.0M |
| Cash From Investing Activities | 867.0M | -63.00M | -553.0M |
| Cash From Financing Activities | 2.256B | -536.0M | 550.0M |
| Net Change In Cash | -264.0M | -86.00M | -294.0M |
| YoY Change | -10.2% | -291.11% | 14.4% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$3.387B | $513.0M | -$291.0M |
| Capital Expenditures | $394.0M | -$171.0M | -$685.0M |
| Free Cash Flow | -$3.781B | $684.0M | $394.0M |
| YoY Change | -1059.64% | -57.41% | -72.25% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2010Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.59 | |
| CY2010Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.76 | |
| CY2009Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.68 | |
| CY2009Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.88 | |
| CY2009Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.07 | |
| CY2009Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.17 | |
| CY2010Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.45 | |
| CY2010Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.22 | |
| CY2010Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.57 | |
| CY2010Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.73 | |
| CY2009Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
657000000 | |
| CY2009Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
720000000 | |
| CY2009Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
786000000 | |
| CY2009Q4 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
836000000 | |
| CY2010Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
533000000 | |
| CY2010Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
718000000 | |
| CY2010Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
565000000 | |
| CY2010Q4 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
829000000 | |
| CY2009Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
9000000 | |
| CY2009Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
14000000 | |
| CY2009Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
11000000 | |
| CY2009Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-9000000 | |
| CY2010Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
14000000 | |
| CY2010Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
107000000 | |
| CY2010Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
6000000 | |
| CY2010Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
154000000 | |
| CY2009Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
666000000 | |
| CY2009Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
734000000 | |
| CY2009Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
797000000 | |
| CY2009Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
827000000 | |
| CY2010 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
364200000 | |
| CY2009Q4 | us-gaap |
Assets
Assets
|
35111000000 | |
| CY2010Q4 | us-gaap |
Assets
Assets
|
35067000000 | |
| CY2009Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
4593000000 | |
| CY2010Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
4507000000 | |
| CY2009Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
111000000 | |
| CY2010Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
189000000 | |
| CY2009Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.69 | |
| CY2009Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.90 | |
| CY2009Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.09 | |
| CY2009Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.19 | |
| CY2010Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.46 | |
| CY2010Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
547000000 | |
| CY2010Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
825000000 | |
| CY2010Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
571000000 | |
| CY2010Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
983000000 | |
| CY2008 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5049000000 | |
| CY2009Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1040000000 | |
| CY2009 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
4415000000 | |
| CY2009Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1063000000 | |
| CY2009Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1068000000 | |
| CY2009Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
10085000000 | |
| CY2010Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.25 | |
| CY2009Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1244000000 | |
| CY2010Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
959000000 | |
| CY2010 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
4097000000 | |
| CY2010Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1121000000 | |
| CY2010Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
889000000 | |
| CY2010Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1128000000 | |
| CY2010Q4 | us-gaap |
Prescription Drug Subsidy Receipts Five Fiscal Years Thereafter
PrescriptionDrugSubsidyReceiptsFiveFiscalYearsThereafter
|
150000000 | |
| CY2010Q4 | us-gaap |
Prescription Drug Subsidy Receipts Year Five
PrescriptionDrugSubsidyReceiptsYearFive
|
40000000 | |
| CY2010Q4 | us-gaap |
Prescription Drug Subsidy Receipts Year Four
PrescriptionDrugSubsidyReceiptsYearFour
|
40000000 | |
| CY2010Q4 | us-gaap |
Prescription Drug Subsidy Receipts Year One
PrescriptionDrugSubsidyReceiptsYearOne
|
30000000 | |
| CY2010Q4 | us-gaap |
Prescription Drug Subsidy Receipts Year Three
PrescriptionDrugSubsidyReceiptsYearThree
|
30000000 | |
| CY2010Q4 | us-gaap |
Prescription Drug Subsidy Receipts Year Two
PrescriptionDrugSubsidyReceiptsYearTwo
|
30000000 | |
| CY2009Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
10940000000 | |
| CY2009Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
10767000000 | |
| CY2009Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
12203000000 | |
| CY2010Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
10339000000 | |
| CY2010Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
11295000000 | |
| CY2010Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
11375000000 | |
| CY2010Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
12794000000 |
